Aytu Biopharma (AYTU) Capital Expenditures (QoQ) (2016 - 2025)
Aytu Biopharma (AYTU) Capital Expenditures (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aytu Biopharma | 1.43 Mn | -25.28 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -75.36% |
| Mar 31, 2025 | 1,050.00% |
| Dec 31, 2024 | -95.59% |
| Sep 30, 2024 | -58.66% |
| Jun 30, 2020 | -533.33% |
| Mar 31, 2020 | -70.00% |
| Jun 30, 2019 | 159.47% |
| Mar 31, 2019 | -193.23% |
| Dec 31, 2018 | 12,990.44% |
| Mar 31, 2017 | 254.93% |
| Dec 31, 2016 | -191.02% |
| Sep 30, 2016 | -40.22% |
| Jun 30, 2016 | 348.62% |
| Mar 31, 2016 | -162.30% |